Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth
Open Access
- 1 August 2002
- journal article
- editorial
- Published by Elsevier BV in Cancer Cell
- Vol. 2 (2), 127-137
- https://doi.org/10.1016/s1535-6108(02)00097-1
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR IS AN AUTOCRINE MEDIATOR OF HUMAN PROSTATE STROMAL CELL GROWTH IN VITROJournal of Urology, 2001
- ZD1839 (???Iressa???)*,??? as an Anticancer AgentDrugs, 2000
- EGF receptorThe International Journal of Biochemistry & Cell Biology, 1999
- Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimersThe EMBO Journal, 1998
- ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalingThe EMBO Journal, 1997
- A novel method for real time quantitative RT-PCR.Genome Research, 1996
- Real time quantitative PCR.Genome Research, 1996
- Epidermal Growth Factor-related Peptides Activate Distinct Subsets of ErbB Receptors and Differ in Their Biological ActivitiesOnline Journal of Public Health Informatics, 1996
- Antigen binding thermodynamics and antiproliferative effects of chimeric and humanized anti-p185HER2 antibody Fab fragmentsBiochemistry, 1992
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987